Submission Information

SHOWCASE YOUR RESEARCH AT THE
ISCT EUROPE 2024 REGIONAL MEETING

With a truly translational focus, the ISCT Europe 2024 Regional Meeting welcomes abstracts from basic science and preclinical studies, clinical investigations, manufacturing, regulatory, quality, policy, ethics, and commercialization. 

Your work is vital to advancing the field of cell and gene therapy. 

Submit your abstract(s) for the opportunity to be considered for an oral abstract or poster presentation to promote your work to key leaders in the CGT sector, gain exposure to potential collaborators and expand your professional network.  

Don't miss this opportunity to present your research with a community of experts across the translation field. 

KEY DATES


SUBMISSION OPENS
March 4, 2024


SUBMISSION CLOSES
June 17, 2024


NOTIFICATION OF ACCEPTANCE AND AWARDS
July 5, 2024


DEADLINE TO RSVP AND REGISTER
July 26, 2024

ABSTRACT CATEGORIES

  • Mesenchymal Stem/Stromal Cells
  • Hematopoietic Stem/Progenitor Cells and Engineering
  • Immunotherapy (CAR-T, T Reg, NK Cells, etc.)
  • Exosomes/EVs
  • iPSC
  • Gene Editing/Gene Therapies
  • Tissue Engineering
  • Embryonic, Organ, and Other Tissue Specific Stem Cells
  • Process Development and Manufacturing
  • Regulatory Affairs, Quality Systems, Policy, Ethics, and Patient Access
  • Workforce Development


Full List of Abstract Categories

ABSTRACT AWARDS

As a general eligibility criteria, individuals must be presenting an abstract at ISCT Europe 2024 and be a current ISCT member.

1 Available | Sponsor: ISCT

The Top Scoring Early Stage Professionals Awards recognize outstanding research submitted by Early Stage Professionals.

  • Specific Eligibility Criteria: Presenter must be an Early Stage Professional. Early Stage Professionals are classified as students or professionals within ten years of their terminal degree or entry into the field of cell and gene therapy.

5 Available | Sponsor: ISCT

Recognizing the breadth and depth of local research, these awards provide a platform to showcase work being performed in the five Nordic countries to a global audience, and offer an opportunity for local researchers to engage with international delegates in attendance.

  • Specific Eligibility Criteria: Recipient must reside in one of the five Nordic countries (Sweden, Norway, Iceland, Finland, Denmark) and be an Early Stage Professional. Early Stage Professionals are classified as students or professionals within ten years of their terminal degree or entry into the field of cell and gene therapy.

1 Available | Sponsor: ISCT

ISCT recognizes that research and innovation begins at "the bench" and have established the Top Scoring Technologist Award to celebrate impactful submissions from laboratory technicians.

  • Specific Eligibility Criteria: Recipient must be a laboratory technician and be employed in technical laboratory settings (laboratory directors and upper management are not eligible). Laboratory technicians typically hold a technical designation (e.g., MLS(ASCP) or equivalent).

PUBLICATION AND FEES

Accepted abstracts will be published in the ISCT Europe 2024 Regional Meeting Program.

There are no fees associated with submitting an abstract. Those presenting abstracts will be responsible for their own registration expenses.


Avoidance of Marketing or Promotion
ISCT requests that presenters avoid the use of trade names and logos for drugs, devices and/or instrumentation in these scientific sessions and to use generic names, where possible. Presentation content will be well-balanced, will be based on generally accepted scientific principles and methods, and will not promote a commercial interest.

GUIDELINES AND POLICIES

  • The abstract body cannot exceed 2500 characters, exclusive of the title, author block, images, and tables.
  • Note that spaces count as characters.
  • Abstracts must be submitted via the online Abstract Submission System. Abstracts will NOT be accepted by email, mail, or fax.
  • ISCT may reject abstracts that are considered inappropriate for any reason. Abstracts, once submitted, can only be withdrawn no later than August 2, 2024. If not withdrawn by this deadline, All accepted abstracts will be published in the final program and abstract supplement.
  • Abstract presenters MUST be registered for the meeting. For those requiring acceptance notifications before registering, ISCT Europe 2024 will allow up to two weeks after acceptance for these individuals to register.

  • Abstracts submitted to the ISCT Europe 2024 Regional Meeting are embargoed from the time of submission.
  • For the abstract to be eligible for presentation at the ISCT Europe 2024 Regional Meeting, information contained within, as well as additional data and information to be presented about the content, may not be published elsewhere or made public before the abstract has been published/presented at the ISCT Europe 2024 Regional Meeting.
  • Authors must notify ISCT if, after the submission deadline, the submitted abstract is accepted for publication elsewhere and will be published before the ISCT Europe 2024 Regional Meeting. Publication before the meeting may result in the abstract being removed from the conference.
  • If the Embargo Policy is violated, the abstract may be withdrawn by ISCT Europe 2024 from presentation at the ISCT Europe 2024 Regional Meeting and from publication in the ISCT Europe 2024 program.

*An embargo means that information from any abstract or presentation may not be announced,
publicized, or distributed before the embargo date and time.